refractory Crohn’s disease

June 9, 2017June 9, 2017

Stem Cell Therapy Potentially Effective in Crohn’s Disease, but Concerns Remain, Review Finds

Crohn's Disease, News

Stem cell therapy was found to be potentially effective and a possible alternative treatment for patients with refractory active Crohn’s disease, according to a meta–analysis review study. Toxicity remains the most ... Read more

December 21, 2015December 21, 2015

Crohn’s Disease Treatment with Blood Stem Cells Shows No Sustained Benefits

News

Researchers in a new study analyzed the outcomes of a clinical trial comparing standard therapy with hematopoietic (blood) stem cell transplantation (HSCT) in Crohn’s disease patients and found that HSCT did not ... Read more

June 30, 2015June 30, 2015

FDA Accepts TxCell’s IND Application To Treat Refractory Crohn’s Disease

News

TxCell SA is a biotechnology firm advancing innovative and personalized T cell immunotherapies utilizing antigen specific regulatory T-cells (Ag-Tregs) to address both severe chronic inflammatory and autoimmune diseases. The company recently announced that the ... Read more

March 25, 2015March 25, 2015

TxCell Receives US Patent For Ovasave To Treat IBD

IBD News, News

A key patent was recently granted by the United States Patent and Trademark Office (USPTO) to TxCell SA for its lead product Ovasave® to address inflammatory bowel disease (IBD). The patent will protect Ovasave until 2030. TxCell SA ... Read more